Clinical Trials

NCT06704763 | COMPLETED | PHASE1

27 participants

A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-12-06

Completion:

2025-02-05

Conditions

• Healthy

Interventions

• DRUG

Results Available

NCT06703125 | RECRUITING | NA

850 participants

The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-02-11

Completion:

2029-02-28

Conditions

• Autism

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT06700122 | COMPLETED | NA

24 participants

Clinical Comparative Evaluation of the Use of Photodynamic Therapy in Conjunction With the Use of Vitamin D in Management Stage II Grade B Periodontitis Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-03-01

Completion:

2025-05-01

Conditions

• Vitamin D Deficiency

Interventions

• DIETARY_SUPPLEMENT

No Results Yet

NCT06698549 | COMPLETED | PHASE1

12 participants

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-02-20

Completion:

2025-07-23

Conditions

• COVID 19

Interventions

• DRUG

No Results Yet

NCT06689930 | RECRUITING | NA

46 participants

Community-based Implementation of Adapted STAC

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-05-22

Completion:

2026-09-30

Conditions

• Blood Pressure
• Hypertension
• Pregnancy Related
• Health Equity

Interventions

• OTHER

No Results Yet

NCT06684522 | RECRUITING | EARLY_PHASE1

10 participants

Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-12-18

Completion:

2027-06-30

Conditions

• Eyelid Dermatitis

Interventions

• DRUG

No Results Yet

NCT06682988 | RECRUITING | PHASE2

110 participants

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-05-28

Completion:

2026-07-31

Conditions

• Advanced High-Grade Epithelial Ovarian Cancer
• Primary Peritoneal Cancer
• Fallopian Tube Cancers

Interventions

• DRUG

No Results Yet

NCT06673303 | COMPLETED | NA

47 participants

Investigating The Role of Noise Correlations in Learning

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-12-14

Completion:

2025-09-01

Conditions

• Noise Correlations
• Learning Quality

Interventions

• BEHAVIORAL
• DIAGNOSTIC_TEST

No Results Yet

NCT06667700 | RECRUITING | PHASE3

3082 participants

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-12-02

Completion:

2031-01-26

Conditions

• Coronavirus Disease (COVID-19)

Interventions

• DRUG

No Results Yet

NCT06659029 | RECRUITING

442 participants

Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-26

Start Date:

2025-07-01

Completion:

2031-04-15

Conditions

• Systemic Lupus Erythematosus

Interventions

• DRUG

No Results Yet

NCT06646523 | COMPLETED | NA

46 participants

Effects of Home-based High-speed Bodyweight Resistance Training in Individual With Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-10-18

Completion:

2026-03-31

Conditions

• Parkinson Disease

Interventions

• OTHER

No Results Yet

NCT06643728 | ACTIVE_NOT_RECRUITING | PHASE2

252 participants

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-10-21

Completion:

2026-01-16

Conditions

• Obesity
• Overweight

Interventions

• DRUG

No Results Yet

NCT06639984 | RECRUITING | PHASE2

110 participants

Psyllium in Pediatric IBS

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-02-20

Completion:

2027-09-30

Conditions

• Irritable Bowel Syndrome

Interventions

• OTHER
• DRUG

No Results Yet

NCT06637332 | RECRUITING | PHASE4

300 participants

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-11-14

Completion:

2027-01-31

Conditions

• Staphylococcus Aureus Septicemia
• Staphylococcus Aureus Bacteremia
• S. Aureus Bacteremia
• S. Aureus Bloodstream Infection
• Staphylococcus Aureus Endocarditis

Interventions

• DRUG

No Results Yet

NCT06631092 | RECRUITING | PHASE1/PHASE2

28 participants

Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-11-20

Completion:

2027-12-31

Conditions

• Triple Negative Breast Cancer

Interventions

• BIOLOGICAL

No Results Yet

NCT06628778 | NOT_YET_RECRUITING | PHASE3

802 participants

Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2027-04-15

Completion:

2034-04-15

Conditions

• Venous Thromboembolism (VTE)

Interventions

• DRUG

No Results Yet

NCT06612151 | ACTIVE_NOT_RECRUITING | PHASE3

438 participants

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-12-17

Completion:

2027-12-01

Conditions

• Small Cell Lung Cancer

Interventions

• DRUG

No Results Yet

NCT06607185 | ACTIVE_NOT_RECRUITING | PHASE1

750 participants

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-10-21

Completion:

2030-01-31

Conditions

• Pancreatic Ductal Adenocarcinoma
• Non-small Cell Lung Cancer
• Colorectal Cancer
• Advanced Solid Tumor
• Metastatic Solid Tumor

Interventions

• DRUG

No Results Yet

NCT06603558 | RECRUITING

3000 participants

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-26

Start Date:

2024-09-24

Completion:

2029-05-31

Conditions

• Chronic Migraine
• Episodic Migraine
• Migraine

Interventions

• DRUG

No Results Yet

NCT06601686 | RECRUITING | NA

22 participants

Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-01-08

Completion:

2027-01-31

Conditions

• Healthy

Interventions

• DEVICE

No Results Yet

NCT06596473 | RECRUITING | PHASE1

310 participants

A Study of BG-C477 in Participants With Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-10-03

Completion:

2027-12-31

Conditions

• Advanced Solid Tumors

Interventions

• DRUG

No Results Yet

NCT06595056 | ENROLLING_BY_INVITATION | NA

200 participants

Primary Care Referrals to a Remotely Delivered Physical Activity Intervention for Latina Teens: Chicas Fuertes 2

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-04-10

Completion:

2028-12-31

Conditions

• Physical Activity

Interventions

• BEHAVIORAL

No Results Yet

NCT06588699 | RECRUITING | PHASE2

144 participants

Digoxin In NASH (CODIN)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-06-05

Completion:

2029-01-31

Conditions

• NASH
• NAFLD
• MASH - Metabolic Dysfunction-Associated Steatohepatitis
• Mash
• MASH With Fibrosis
• MASLD
• Fatty Liver Disease
• Fatty Liver Disease, Nonalcoholic

Interventions

• DRUG

No Results Yet

NCT06586190 | NOT_YET_RECRUITING | NA

20 participants

Outpatient Floor Pedal Bike Utilization

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2026-08-31

Completion:

2028-12-31

Conditions

• Femur Fracture
• Tibia Fracture
• Ankle Injuries

Interventions

• OTHER

No Results Yet

NCT06585774 | RECRUITING | PHASE3

240 participants

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-01-21

Completion:

2027-09-28

Conditions

• Chronic Graft-versus-host-disease

Interventions

• DRUG

No Results Yet

NCT06574880 | RECRUITING | PHASE1/PHASE2

45 participants

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-05-13

Completion:

2026-09-01

Conditions

• Malignant Neoplasm of Prostate
• Locally Advanced Prostate Cancer

Interventions

• DRUG
• RADIATION

No Results Yet

NCT06568861 | COMPLETED | PHASE1

16 participants

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-01-13

Completion:

2025-07-16

Conditions

• COVID-19

Interventions

• DRUG

No Results Yet

NCT06561360 | RECRUITING | PHASE2

86 participants

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-09-09

Completion:

2027-09-09

Conditions

• Hairy Cell Leukemia

Interventions

• DRUG

No Results Yet

NCT06552741 | RECRUITING

10000 participants

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-26

Start Date:

2024-09-04

Completion:

2045-01-01

Conditions

• Substance Use Disorder
• Alcohol Use Disorder

No Results Yet

NCT06551558 | RECRUITING | NA

174 participants

Impact of a Global Warming Strategy of the Patient on the Prevalence of Hypothermia in the Recovering Room

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-11-08

Completion:

2026-11-30

Conditions

• Hypothermia; Anesthesia
• Perioperative/Postoperative Complications

Interventions

• OTHER

No Results Yet

NCT06548191 | RECRUITING | PHASE1

60 participants

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-04-23

Completion:

2027-04-30

Conditions

• Mild Cognitive Impairment
• Alzheimer Disease
• Alzheimer's Disease

Interventions

• BEHAVIORAL

No Results Yet

NCT06543368 | COMPLETED | NA

14 participants

Low-Cost Platelet-Rich Plasma for Hemarthropathy

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-07-23

Completion:

2025-05-05

Conditions

• Hemarthrosis
• Hemophilia

Interventions

• BIOLOGICAL

Results Available

NCT06541535 | RECRUITING | PHASE4

300 participants

Fluid Administration in Ketoacidosis (DRINK)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2025-11-26

Completion:

2027-12-31

Conditions

• Diabetic Keto-acidosis

Interventions

• DRUG

No Results Yet

NCT06537999 | RECRUITING | PHASE2

36 participants

A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-09-17

Completion:

2026-06-30

Conditions

• Multifocal Motor Neuropathy

Interventions

• DRUG

No Results Yet

NCT06535607 | RECRUITING | PHASE2

257 participants

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-08-22

Completion:

2028-11-30

Conditions

• Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)
• Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)
• Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
• Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
• Sub-study 5 Unresectable Pleural Mesothelioma (Volrustomig Monotherapy)

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT06533059 | ACTIVE_NOT_RECRUITING | PHASE1

110 participants

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-08-22

Completion:

2026-12-29

Conditions

• Cancer
• Breast Cancer
• Endometrial Cancer
• Metastatic Cancer
• Advanced Solid Tumor

Interventions

• DRUG

No Results Yet

NCT06528353 | NOT_YET_RECRUITING | NA

10000 participants

Blood Biomarkers Based Screening for HPV-driven OPC

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2026-09-30

Completion:

2032-09-30

Conditions

• Head and Neck Squamous Cell Carcinoma
• Anal Cancer
• Human Papilloma Virus

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT06517693 | RECRUITING | PHASE1

48 participants

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2026-01-05

Completion:

2027-12-31

Conditions

• HIV-1

Interventions

• DRUG

No Results Yet

NCT06516887 | TERMINATED | PHASE1/PHASE2

4 participants

Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2024-12-27

Completion:

2026-05-21

Conditions

• Advanced Lung Adenocarcinoma

Interventions

• DRUG

No Results Yet

NCT06513026 | RECRUITING | NA

40 participants

Milk for Diabetes Prevention

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-26

Start Date:

2026-05-15

Completion:

2028-04-30

Conditions

• Lactose Intolerance
• Lactose Intolerant
• Lactase Persistence
• Pre-Diabetes
• Diabetes Mellitus, Type 2

Interventions

• DIETARY_SUPPLEMENT

No Results Yet